Vanguard Group Inc's Updated Ownership in Maravai LifeSciences Holdings Inc

The Vanguard Group Inc has filed an amendment to its Schedule 13G, reporting its updated ownership in Maravai LifeSciences Holdings Inc. As of September 30, 2025, Vanguard owns 7,125,498 shares, representing 4.92% of the company's common stock. This marks a decrease of 2,255,049 shares from its previous filing, a reduction of 24.04%. The value of these shares is approximately $22,374,063.72, a decrease of 1.03% from the previous value. Vanguard's ownership is held on behalf of its clients, including investment companies and managed accounts, with no single client owning more than 5% of the shares. The filing was signed by Ashley Grim, Head of Global Fund Administration, on October 31, 2025.